Facebook Linkedin RSS Twitter Youtube
Home 2024

Genetic diseases

RNA Editing Therapy Developer Closes $60M Series A Financing
Drug Discovery

RNA Editing Therapy Developer Closes $60M Series A Financing

StockWatch: Phase III Data for Pfizer-Partnered Hemophilia A Gene Therapy Lifts Sangamo Shares
GEN Edge

StockWatch: Phase III Data for Pfizer-Partnered Hemophilia A Gene Therapy Lifts Sangamo Shares

Genetic Disorders Diagnosed More Quickly via Long-Read Sequencing Method
Featured

Genetic Disorders Diagnosed More Quickly via Long-Read Sequencing Method

Inflammation in Macrophages Found as a Driving Force in Rare Genetic Conditions
News

Inflammation in Macrophages Found as a Driving Force in Rare Genetic Conditions

Small-Molecule “Unsilencers” Show Promise against Angelman Syndrome
Drug Discovery

Small-Molecule “Unsilencers” Show Promise against Angelman Syndrome

Gee WIZ: Novartis’ “Glue Degrader” Drug Candidate for Sickle Cell Shows Promise in Animal Studies
GEN Edge

Gee WIZ: Novartis’ “Glue Degrader” Drug Candidate for Sickle Cell Shows Promise in Animal Studies

RNA Splicing Visualized, Easing the Design of Small-Molecule Modulators
Drug Discovery

RNA Splicing Visualized, Easing the Design of Small-Molecule Modulators

Standardized Cell and Gene Therapy Hub A Call to Action
Bioprocessing

Standardized Cell and Gene Therapy Hub A Call to Action

Neurodegeneration Due to Ultra-Rare Disease Slowed by AAV Gene Therapy
Drug Discovery

Neurodegeneration Due to Ultra-Rare Disease Slowed by AAV Gene Therapy

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga
GEN Edge

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga

1...345...89Page 4 of 89
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.